Nationwide screening for Fabry disease in unselected stroke patients.
Plos One
Tomek, Aleš A; Petra, Reková R; Paulasová Schwabová, Jaroslava J; Olšerová, Anna A; Škorňa, Miroslav M; Nevšímalová, Miroslava M; Šimůnek, Libor L; Herzig, Roman R; Fafejtová, Štěpánka Š; Mikulenka, Petr P; Táboříková, Alena A; Neumann, Jiří J; Brzezny, Richard R; Sobolová, Helena H; Bartoník, Jan J; Václavík, Daniel D; Vachová, Marta M; Bechyně, Karel K; Havlíková, Hana H; Prax, Tomáš T; Šaňák, Daniel D; Černíková, Irena I; Ondečková, Iva I; Procházka, Petr P; Rajner, Jan J; Škoda, Miroslav M; Novák, Jan J; Škoda, Ondřej O; Bar, Michal M; Mikulík, Robert R; Dostálová, Gabriela G; Linhart, Aleš A; ,
Nationwide screening for Fabry disease in unselected stroke patients.
Plos One
Tomek, Aleš A; Petra, Reková R; Paulasová Schwabová, Jaroslava J; Olšerová, Anna A; Škorňa, Miroslav M; Nevšímalová, Miroslava M; Šimůnek, Libor L; Herzig, Roman R; Fafejtová, Štěpánka Š; Mikulenka, Petr P; Táboříková, Alena A; Neumann, Jiří J; Brzezny, Richard R; Sobolová, Helena H; Bartoník, Jan J; Václavík, Daniel D; Vachová, Marta M; Bechyně, Karel K; Havlíková, Hana H; Prax, Tomáš T; Šaňák, Daniel D; Černíková, Irena I; Ondečková, Iva I; Procházka, Petr P; Rajner, Jan J; Škoda, Miroslav M; Novák, Jan J; Škoda, Ondřej O; Bar, Michal M; Mikulík, Robert R; Dostálová, Gabriela G; Linhart, Aleš A; ,
Assessment of Gene Variant Amenability for Pharmacological Chaperone Therapy with 1-Deoxygalactonojirimycin in Fabry Disease.
International Journal Of Molecular Sciences
Lukas, Jan J; Cimmaruta, Chiara C; Liguori, Ludovica L; Pantoom, Supansa S; Iwanov, Katharina K; Petters, Janine J; Hund, Christina C; Bunschkowski, Maik M; Hermann, Andreas A; Cubellis, Maria Vittoria MV; Rolfs, Arndt A
Xiao, Ke K; Lu, Dongchao D; Hoepfner, Jeannine J; Santer, Laura L; Gupta, Shashi S; Pfanne, Angelika A; Thum, Sabrina S; Lenders, Malte M; Brand, Eva E; Nordbeck, Peter P; Thum, Thomas T
Oral Chaperone Therapy Migalastat for Treating Fabry Disease: Enzymatic Response and Serum Biomarker Changes After 1 Year.
Clinical Pharmacology And Therapeutics
Müntze, Jonas J; Gensler, Daniel D; Maniuc, Octavian O; Liu, Dan D; Cairns, Tereza T; Oder, Daniel D; Hu, Kai K; Lorenz, Kristina K; Frantz, Stefan S; Wanner, Christoph C; Nordbeck, Peter P
Characterization of Classical and Nonclassical Fabry Disease: A Multicenter Study.
Journal Of The American Society Of Nephrology : Jasn
Arends, Maarten M; Wanner, Christoph C; Hughes, Derralynn D; Mehta, Atul A; Oder, Daniel D; Watkinson, Oliver T OT; Elliott, Perry M PM; Linthorst, Gabor E GE; Wijburg, Frits A FA; Biegstraaten, Marieke M; Hollak, Carla E CE
Alpha-Galactosidase A p.A143T, a non-Fabry disease-causing variant.
Orphanet Journal Of Rare Diseases
Lenders, Malte M; Weidemann, Frank F; Kurschat, Christine C; Canaan-Kühl, Sima S; Duning, Thomas T; Stypmann, Jörg J; Schmitz, Boris B; Reiermann, Stefanie S; Krämer, Johannes J; Blaschke, Daniela D; Wanner, Christoph C; Brand, Stefan-Martin SM; Brand, Eva E